Effect of COX-2 Selective Inhibitors on Postoperative Insulin Resistance After Gastrointestinal Laparoscopic Surgery

NCT01930318 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

164

Enrollment

OTHER

Sponsor class

Conditions

Gastrointestinal Cancer

Interventions

DRUG: parecoxib

Sponsor

Jinling Hospital, China

Collaborators

[object Object]